Our No1 Takeover Target for NOV

Here's the next biotech we think could soar 1,000% Greetings to you on this day: November 04, 2021 Fellow Investor, There's no sector poised to deliver bigger gains in 2021 than small-cap [biotech stocks.]( In the past year alone... - Novavax Inc jumped from $6.26 to $270.51, a gain of 3,396%. - Aclaris Therapts jumped from $0.70 to $24.28 an increase of 1,583%. - Vaxart Inc rocketed from $0.97 to $14.94, a 1,083% jump. [Here's the next biotech we think could soar 1,000% ]( What drives massive gains like that? It usually comes when a biotech unveils a unique new drug. On December 5, 2020, a small Cambridge biotech shocked the world when they could "Find & Replace" the genes that cause the disease anemia. This revolutionary new kind of treatment may not just change sickle cell anemia - It has the potential to eliminate genetic disease from our species. If that sounds like science fiction, consider this - - The Nobel Prize Committee is calling it "The Holy Grail of Medicine." - The Wall Street Journal reports the company is "transforming medicine." - 60 Minutes reports the company is "revolutionizing the search for new drugs." [Here's the next biotech we think could soar 1,000% ]( Investor's Business Daily estimates the market is worth at least $75 billion. But right now, its stock price is just a tiny fraction of that size. [Our research proves that anyone who gets in today could see a 46,751% return (or more)!]( That's if the company doesn't get taken over for fast 300% gains first. [CLICK HERE to see how you can profit from this unique opportunity ]( Sincerely, Dylan J. Chairman Behind the Markets --------------------------------------------------------------- --------------------------------------------------------------- There is a very high degree of risk involved in trading. Rise To Trade and all individuals affiliated with this site assume no responsibility for your trading and investment results. The indicators, strategies, columns, and all other features are for educational purposes only and should not be construed as investment advice. Information for futures trading observations are obtained from sources believed to be reliable, but we do not warrant its completeness or accuracy, or warrant any results from the use of the information. Your use of the trading observations is entirely at your own risk and it is your sole responsibility to evaluate the accuracy, completeness and usefulness of the information. You must assess the risk of any trade with your broker and make your own independent decisions regarding any securities mentioned herein. Rise To Trade, 7407271, 472 Amherst St., Unit 7407271, Nashua, NH, 03063 [Click here to unsubscribe](